Sinovac Biotech SVA
NASDAQ SVA
$6.47 +0.00 (+0.00%)
At close: Oct 28, 2026 · 4:00 PM EDT

Sinovac Biotech (SVA) Gains from Sales and Divestitures (2009 - 2020)

Updated

Analysis

Sinovac Biotech (SVA) Gains from Sales and Divestitures (2009 - 2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Sinovac Biotech 464.94 Mn -24.98 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 115,000.00
Sep 30, 2020 15,000.00
Jun 30, 2020 22,000.00
Mar 31, 2020 11,000.00
Dec 31, 2019 64,000.00
Sep 30, 2019 177,000.00
Jun 30, 2019 27,000.00
Mar 31, 2019 26,000.00
Dec 31, 2018 6,000.00
Sep 30, 2018 51,000.00
Jun 30, 2018 2,000.00
Mar 31, 2018 20,000.00
Dec 31, 2016 75,000.00
Sep 30, 2016 308,000.00
Jun 30, 2016 78,000.00
Mar 31, 2016 43,000.00
Dec 31, 2015 52,000.00
Sep 30, 2015 -11,000.00
Jun 30, 2015 -24,000.00
Dec 31, 2014 44,000.00
API Access

Sinovac Biotech Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=SVA&period=max&api_key=YOUR_API_KEY